BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND KMT2C, ENSG00000055609, MLL3, 58508 AND Prognosis
6 results:

  • 1. Association of the Genomic Profile of Medullary Thyroid Carcinoma with tumor Characteristics and Clinical Outcomes in an International Multicenter Study.
    Xu B; Viswanathan K; Ahadi MS; Ahmadi S; Alzumaili B; Bani MA; Baudin E; Behrman DB; Capelletti M; Chau NG; Chiarucci F; Chou A; Clifton-Bligh R; Coluccelli S; de Biase D; De Leo A; Dogan S; Fagin JA; Fuchs TL; Glover AR; Hadoux J; Lacroix L; Lamartina L; Lubin DJ; Luxford C; Magliocca K; Maloberti T; Mohanty AS; Najdawi F; Nigam A; Papachristos AJ; Repaci A; Robinson B; Scoazec JY; Shi Q; Sidhu S; Solaroli E; Sywak M; Tuttle RM; Untch B; Barletta JA; Al Ghuzlan A; Gill AJ; Ghossein R; Tallini G; Ganly I
    Thyroid; 2024 Feb; 34(2):167-176. PubMed ID: 37842841
    [No Abstract]    [Full Text] [Related]  

  • 2. Comprehensive genomic analysis of primary malignant melanoma of the esophagus reveals similar genetic patterns compared with epithelium-associated melanomas.
    Li J; Liu B; Ye Q; Xiao X; Yan S; Guan W; He L; Wang C; Yu Z; Tai Z; Pei S; Ma Y; Li S; Wang Y; Wu N
    Mod Pathol; 2022 Nov; 35(11):1596-1608. PubMed ID: 35688970
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. kmt2c is a Potential Biomarker of Anti-PD-1 Treatment Response in Metastatic Melanoma.
    Xie K; Peng Y; Zhong W; Liu X
    Front Biosci (Landmark Ed); 2022 Mar; 27(3):103. PubMed ID: 35345335
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Pathological and genomic phenotype of second neuroendocrine carcinoma during long-term follow-up after radical radiotherapy for nasopharyngeal carcinoma.
    Peng YP; Liu QD; Lin YJ; Peng SL; Wang R; Xu XW; Wei W; Zhong GH; Zhou YL; Zhang YQ; Liu Y; Wang SY; Hong HY; Liu ZG
    Radiat Oncol; 2021 Oct; 16(1):198. PubMed ID: 34635145
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Integrative Genomic Characterization Identifies Molecular Subtypes of Lung Carcinoids.
    Laddha SV; da Silva EM; Robzyk K; Untch BR; Ke H; Rekhtman N; Poirier JT; Travis WD; Tang LH; Chan CS
    Cancer Res; 2019 Sep; 79(17):4339-4347. PubMed ID: 31300474
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Principles of tumorigenesis and emerging molecular drivers of SHH-activated medulloblastomas.
    Menyhárt O; Győrffy B
    Ann Clin Transl Neurol; 2019 May; 6(5):990-1005. PubMed ID: 31139698
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.